Established in 2007, Narimya Pharmaceuticals Inc. set out to provide Canadians with a growing list of quality, healthcare-related products from Switzerland.
Our founder is a veteran of the Swiss pharmaceutical industry with an extensive background in pharma-retail and wholesale distribution. Dr. Charles Piwko, President and CEO of Narimya Pharmaceuticals Inc., holds a PhD in Pharmacology (ETH Zurich), a PharmD (ETH Zurich) and an MSc in Health Administration (Health Economics, University of Toronto).
Upon arrival in Canada, Dr. Piwko began developing his distribution business while concurrently providing pharmaceutical, biotechnology, and medical device companies with high-quality consulting services in the areas of health outcomes, economics, and market access research. In this capacity, Dr. Piwko is now a principal in CHP Pharma Inc. Over time, Dr. Piwko has gained valuable, Canadian, pharma-retail market experience and is now exceptionally well-positioned to build a successful Canadian-based, consumer healthcare business.
Prior to coming to Canada, Dr. Piwko held a senior position with ‘Pharmacy 12’, a large retail pharmacy in Zurich, where he gained experience with OTCs and prescription drugs; he also worked in the Department of Preclinical CNS-Pharmacology at Sandoz (Novartis) Pharma AG in Basel, Switzerland in association with the ETHZ.
For more information email us at: email@example.com
Founder and CEO - Dr. Charles Piwko CMO, CFO - Mr. Ariel Piwko